BIGT vs. EDIV ETF Comparison
Comparison of L&G Pharma Breakthrough UCITS ETF (BIGT) to Lyxor S&P Eurozone ESG Dividend Aristocrats (DR) UCITS ETF EUR Acc GBP (EDIV)
BIGT
L&G Pharma Breakthrough UCITS ETF
BIGT Description
The objective of the fund is to provide exposure to a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The Index selects stocks that meet certain size and liquidity requirements using a two-fold approach that is primarily based on the trend in the valuation of a companyâs orphan drug portfolio and its overall revenue forecasts.
Grade (RS Rating)
Last Trade
£749.05
Average Daily Volume
2,747
8
EDIV
Lyxor S&P Eurozone ESG Dividend Aristocrats (DR) UCITS ETF EUR Acc GBP
EDIV Description
NAGrade (RS Rating)
Last Trade
£8.76
Average Daily Volume
3,276
22
Performance
| Period | BIGT | EDIV |
|---|---|---|
| 30 Days | -4.15% | -0.85% |
| 60 Days | -4.87% | 0.59% |
| 90 Days | -3.52% | |
| 12 Months | -18.30% |
1 Overlapping Holdings
| Symbol | Grade | Weight in BIGT | Weight in EDIV | Overlap | |
|---|---|---|---|---|---|
| 0MH6 | A | 2.75% | 1.67% | 1.67% |
BIGT Underweight 21 Positions Relative to EDIV
| Symbol | Grade | Weight | |
|---|---|---|---|
| 0M6S | A | -5.18% | |
| 0NV5 | A | -5.15% | |
| 0II2 | A | -5.15% | |
| 0HAN | D | -4.99% | |
| 0H3Q | D | -3.95% | |
| 0MW7 | A | -3.36% | |
| 0NWF | D | -3.32% | |
| 0NZT | A | -3.05% | |
| 0AC9 | F | -2.57% | |
| 0NZM | A | -2.48% | |
| 0MHC | D | -2.15% | |
| 0NW4 | D | -2.07% | |
| KYGA | B | -1.51% | |
| 0NVV | A | -1.47% | |
| 0NX3 | A | -1.41% | |
| 0O14 | F | -1.23% | |
| 0ML1 | F | -1.2% | |
| 0NTI | B | -1.16% | |
| 0K9W | B | -1.03% | |
| 0G6T | C | -0.95% | |
| 0HZD | C | -0.88% |
BIGT: Top Represented Industries & Keywords
EDIV: Top Represented Industries & Keywords
Compare ETFs
